Who makes Ritodrine Oral Tablet?

Ritodrine Oral Tablet is developed by Cairo University.

What development phase is Ritodrine Oral Tablet in?

Ritodrine Oral Tablet is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Ritodrine Oral Tablet

Cairo University · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Ritodrine Oral Tablet
Also known as	Yutopar
Sponsor	Cairo University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ritodrine Oral Tablet CI brief — competitive landscape report
Ritodrine Oral Tablet updates RSS · CI watch RSS
Cairo University portfolio CI